Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - 16866 - adhesive tape, general-purpose - fabric plasters are suitable for covering all types of smaller wounds. the material stretches with the skin's movements. the non-stick wound pad protects and cushions the wound. assorted shapes for various applications

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

ego pharmaceuticals pty ltd - 17552 - comb, lice - lice comb to be used to detect and remove head lice and eggs.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - 44990 - adhesive strip, skin-cover - a small, narrow flexible band (of fabric, plastic, paper or other material) coated on one side with a pressure sensitive adhesive, typically used to cover or approximate the edges of superficial wounds of fix dressings to skin. the device may include an adhesive pad and have qualities such as hypoallergenic or waterproof. the device is usually supplied sterile in precut sizes/shapes. this is a single-use device.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - 16866 - adhesive tape, general-purpose - a very long and narrow flexible band (of fabric, plastic, paper or other material) coated on one side with a pressure-sensitive adhesive, used to cover a surface, (e.g. a small wound), fix a dressing or attach objects. the device may also be applied in several layers, one overlapping the other, to cover and exert pressure on a body part (e.g. a limb). this is a single use device.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - 61694 - skin-cleaning wipe, non-sterile - a non-sterile device consisting of an absorbent fabric pre-soaked in a liquid solution (a detergent) intended for cleaning a localized body surface before a procedure or device application, and/or to maintain skin hygiene. it is commonly known as a wet wipe and is normally available over-the-counter otc for use in the home or healthcare facility. this is a single use device.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

brady australia pty ltd - 44039 - first aid kit, medicated - the kit is a convenient collection of equipment and materials intended for the rapid, initial treatment of an injury.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - valsartan (unii: 80m03yxj7i) (valsartan - unii:80m03yxj7i) - valsartan 160 mg - valsartan tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which valsartan principally belongs. there are no controlled trials in hypertensive patients demonstrating risk reduction with valsartan tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection,

Stati Uniti - Ingliż - NLM (National Library of Medicine)

par pharmaceutical, inc. - lamotrigine (unii: u3h27498ks) (lamotrigine - unii:u3h27498ks) - lamotrigine 25 mg - lamotrigine extended-release is indicated as adjunctive therapy for primary generalized tonic-clonic (pgtc) seizures and partial-onset seizures with or without secondary generalization in patients aged 13 years and older. lamotrigine extended-release is indicated for conversion to monotherapy in patients aged 13 years and older with partial-onset seizures who are receiving treatment with a single antiepileptic drug (aed). safety and effectiveness of lamotrigine extended-release have not been established (1) as initial monotherapy or (2) for simultaneous conversion to monotherapy from two or more concomitant aeds. safety and effectiveness of lamotrigine extended-release for use in patients younger than 13 years have not been established. lamotrigine extended-release is contraindicated in patients who have demonstrated hypersensitivity (e.g., rash, angioedema, acute urticaria, extensive pruritus, mucosal ulceration) to the drug or its ingredients [see boxed warning, warnings and precautions (5.1, 5.3)] . pregna

Stati Uniti - Ingliż - NLM (National Library of Medicine)

medsource pharmaceuticals - benazepril hydrochloride (unii: n1sn99t69t) (benazeprilat - unii:jrm708l703) - benazepril hydrochloride 20 mg - benazepril hydrochloride tablets, usp are indicated for the treatment of hypertension. it may be used alone or in combination with thiazide diuretics. benazepril hydrochloride tablets are contraindicated in patients who are hypersensitive to benazepril or to any other ace inhibitor. benazepril hydrochloride tablets are also contraindicated in patients with a history of angioedema with or without previous ace inhibitor treatment. do not co-administer aliskiren with angiotensin receptor blockers, ace inhibitors, including benazepril hydrochloride in patients with diabetes.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

remedyrepack inc. - paroxetine hydrochloride hemihydrate (unii: x2els050d8) (paroxetine - unii:41vrh5220h) - paroxetine 20 mg - major depressive disorder: paroxetine tablets are indicated for the treatment of major depressive disorder. the efficacy of paroxetine tablets in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical pharmacology: clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the effects of paroxetine tablets in hospitalized depressed patients have not been adeq